BPC-157: A synthetic 15-amino acid peptide structurally derived from a protein naturally found in gastric secretions
Clinical studies have shown that, when combined with semaglutide, it can achieve an average weight loss of over 20% within 68 weeks
For example, in head-to-head trials, patients on the highest dose of Zepbound lost up to 22.5% of their body weight over 72 weeks, while those taking semaglutide GLP-1 (Wegovy) lost about 15% over a similar period
If you have a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, or youre pregnant or breastfeeding, semaglutide at any dose is off the table
Visible outcomes typically include: Smoother texture : Fine lines and rough patches become less noticeable as collagen and elastin levels improve
Wu X, et al